title: A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia.
authors: Regina M
authors: RM
authors: Leger
authors: Patricia A
authors: PA
authors: Arndt
authors: George
authors: G
authors: Garratty
mesh_terms: D000372:Agglutination Tests; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D015313:Cefotetan / Q000009:adverse effects*; D002443:Ceftriaxone / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000150:complications* / Q000209:etiology; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D015313:Cefotetan; D002443:Ceftriaxone